R01 Fund LP - 16 Jan 2026 SCHEDULE 13D/A Report for NovaBay Pharmaceuticals, Inc. Common Stock, $0.01 par value (NBY)

Filing Manager
R01 Fund LP
Reporting Manager
R01 Fund LP
Security
NovaBay Pharmaceuticals, Inc. Common Stock, $0.01 par value
Symbol
NBY
Shares outstanding
126,235,733 shares
Disclosed Ownership
56,806,080 shares
Ownership
45%
Form type
SCHEDULE 13D/A
Filing time
21 Jan 2026, 20:11:29 UTC
Date of event
16 Jan 2026
Previous filing
20 Oct 2025
Next filing
02 Apr 2026
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"R01 Fund LP disclosed 45% ownership in NovaBay Pharmaceuticals, Inc. Common Stock, $0.01 par value (NBY) on 16 Jan 2026."

Quick Takeaways

  • R01 Fund LP filed SCHEDULE 13D/A for NovaBay Pharmaceuticals, Inc. Common Stock, $0.01 par value (NBY).
  • Disclosed ownership: 45%.
  • Date of event: 16 Jan 2026.

What Changed

  • Previous schedule filing date: 20 Oct 2025.
  • Current filing was accepted on 21 Jan 2026, 20:11.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
R01 Fund LP 45% 56,806,080 0 56,806,080 /s/ Michael Kazley Michael Kazley / Principal 0001990517
R01 Capital LLC 45% 56,806,080 0 56,806,080 /s/ Michael Kazley Michael Kazley / Managing Member 0002091715
R01 Capital Manager LLC 45% 56,806,080 0 56,806,080 /s/ Michael Kazley Michael Kazley / Managing Member 0002091724
Kazley Michael John 45% 56,806,080 0 56,806,080 /s/ Michael Kazley Michael Kazley 0002091727

Sponsored